About US
Contact us
-
China rounds up counterfeiters as the FDA boosts its oversight thereChinaagreed this month to allow the U.S. FDA to send more people there so it can boost its oversight of Chinese drug production. But as if to prove that it has the situation under control, Chinese aut2013/12/17
-
NIH Network Revolutionises Stroke Clinical ResearchA network of 25 regional stroke centers working with nearby satellite facilities will span the country, have teams of researchers representing every medical specialty needed for stroke care and will a2013/12/16
-
FDA Approves First Generic Versions of Antidepressant Drug CymbaltaFDA hasapproved the first generic versions of Cymbalta (duloxetine delayed-release capsules), a prescription medicine used to treat depression and other conditions. Aurobindo Pharma Ltd, Dr Reddy’s2013/12/16
-
Roche and Prothena to jointly develop and promote antibodies for Parkinson's treatmentRoche and Prothena have entered into a collaboration to develop and commercialise antibodies that target alpha-synuclein, including PRX002, Prothena's monoclonal antibody for the treatment of Parkinso2013/12/13
-
FDA Advisory Committee Votes on Investigational Medicine MetreleptinAstraZeneca and Bristol-Myers Squibb Companyhave announced that FDA Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) recommends the investigational medicine metreleptin for the treatment2013/12/13
-
CVS Caremark and Cardinal Health Announce Creation of Largest Generic Sourcing Entity in USCVS Caremark and Cardinal Healthhave signedan agreement to form the largest generic sourcing entity in the US, which is the world's largest generic drug market. Both companies are contributing their s2013/12/12
-
£3 Million Dementia Consortium Launched to Boost Dementia Drug DiscoveryAs the UK today hosts the first G8 summit on dementia research, a new £3 million Dementia Consortium bringing together research experts from the charitable, academic and private sectors has laun2013/12/12
-
Anakinra licensed in UK to treat CAPS in infants and adultsThe Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK has granted a licence to an interleukin-1 (IL-1) inhibitor Anakinra (Kineret) for the treatment of cryopyrin-associated periodi2013/12/11
-
BMS Presents 4-Year Data from Phase III DASISION TrialBristol-Myers Squibb Company and Otsuka America Pharmaceutical, Inc.have announced 4-year follow-up data from the PhaseIII DASISION study of Sprycel (dasatinib) 100 mg once daily versus imatinib (4002013/12/11
-
China Finally Allows FDA To Add InspectorsPharmalot's Ed Silverman reported that after a year of frustration and delay, the White House has finally reached agreement with the Chinese government to allow FDA to boost its inspection team as par2013/12/10